What is Metro Optics?
Metro Optics operates as a specialized manufacturer of custom contact lenses, catering specifically to the needs of eye care professionals who manage patients with complex ocular conditions. The company's portfolio includes advanced soft, corneal, and scleral lens designs engineered for irregular corneas, keratoconus, and post-surgical recovery. By focusing on high-precision optics, Metro Optics serves as a critical partner for practitioners seeking to improve patient outcomes in challenging clinical scenarios. Their business model integrates product innovation with practitioner education, establishing a comprehensive ecosystem that supports both the technical and clinical requirements of modern optometry.
How much funding has Metro Optics raised?
Metro Optics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Metro Optics
PPP
Public-Private Partnership
What's next for Metro Optics?
With the infusion of this latest capital, Metro Optics is poised to transition into a more aggressive phase of market expansion and technological development. The strategic focus will likely center on scaling manufacturing capabilities to meet the rising demand for specialty lenses while simultaneously enhancing their digital practitioner resources. As the company matures, the emphasis will shift toward solidifying its competitive moat through continued investment in R&D and expanding its footprint within the global eye care community. This late-stage financing provides the necessary liquidity to pursue long-term growth initiatives, including potential market diversification and the optimization of supply chain efficiencies to better serve their specialized client base.
See full Metro Optics company page
